The second annual conference of the Institute for Medicines and Medical Devices of Montenegro (CInMED) entitled "Synergy of regulation and science on the European path" was opened in Budva.
"Numerous guests from the country and abroad, representatives of the Government, the academic community and international institutions, regulatory bodies from the region, the pharmaceutical sector, as well as experts and external collaborators of the Institute had the opportunity to familiarize themselves with the results of work, achievements and plans of this institution," it says. in the statement.
"Tonight, I stand before you with sincere joy, because we have gathered in such numbers, not only to review statistics and achievements, but to celebrate together what numbers cannot convey - the dedication, love for the profession and the joint effort that we invested in our Institute for Medicines and Medical Devices. We managed to position the Institute, both nationally and internationally, as an institution that guarantees the quality, safety and efficiency of drugs and medical devices, and in whose work citizens and the entire health system can have a lot trust," said the director of CInMED, Snežana Mugoša, opening the second annual conference of that institution.
Mugoša presented, as stated, the results achieved by the Institute in the past year, emphasizing independence, impartiality and transparency as the fundamental principles that define this institution.
"When we look back at the past, we have many reasons to be proud. And when we look to the future, we see great opportunities ahead. Our pro-European commitment does not only represent our orientation towards European values and the highest standards in the field of medicines and medical devices, but also the way which builds bridges of cooperation and the achievement of common goals in the field of global harmonization and innovation. Our work carries the burden of responsibility and challenges, but precisely those challenges make us stronger and shape the character of our institution. In this endeavor, health as an absolute priority occupies a central place, representing only the foundation, but also the main driver of the common story of all of us who are here tonight," Mugoša said.
The statement added that she expressed her gratitude to the Vice President of the Government of Montenegro, Srđan Pavićević, as well as the Ministry of Health for their support in achieving common goals and commitment to improving the health system.
"I especially want to express my gratitude for the support that the Institute received from the highest representatives of the European Commission, the European Medicines Agency, as well as European and international regulatory authorities in the field of medicines and medical devices on the Institute's further development path and joining European regulatory authorities, in some jurisdictions even before the accession of Montenegro to the European Union", said Mugoša.
She stated that today the Institute has 70 employees, and she gave them sincere recognition for the results achieved.
"As someone who witnesses your extraordinary dedication and hard work every day, I can say with all my heart that you are the inspiration and strength that moves our Institute forward. I thank you for everything you do and look forward to writing new chapters of our successful story together," added Mugoša and wished everyone a successful Conference.
The Vice President of the Government of Montenegro, Srđan Pavićević, expressed his gratitude for the opportunity to congratulate the Institute for Medicines and Medical Devices, the announcement states, on the achievements and the introduction of innovations and modern standards into the regulatory environment in the field of drugs and medical devices.
"As an independent regulatory body, the Institute managed to carry out all its powers transferred by law in accordance with the highest European and international standards in a transparent and efficient manner. In a very short period, the acceleration of all processes in the Institute is noticeable, some by more than five times, and on satisfaction of clients and all participants in the health care system. Thanks to a significantly larger number of approved innovative and generic drugs, not only increased availability of therapeutic options for our health workers and patients, but also multimillion-dollar savings in the budget allocated to health care," he said Pavićević.
In particular, he pointed out that the commitment and achieved results of the Institute have been recognized by numerous European and international bodies, as well as within the European integration process.
"The institute represents a bright example for all institutions that strive to develop and act in the national interest, and becomes a bridge to a healthier future, where the standards of quality, safety and efficiency of medicines and medical devices reach new heights", said Pavićević and officially declared the 2nd annual The conference of the Institute is open.
The Director of the European Medicines Agency (EMA), Emer Cook, also addressed the audience through a video, expressing in this way extremely significant support and recognition for the Institute on its European journey.
She praised the Institute's efforts in the process of European integration and congratulated her on the exceptional results and reforms implemented.
"Our goal in the next three years is to work with candidate countries and potential candidates. We will support you on this journey. We will share our knowledge and experience in working with thousands of experts across Europe. You will have my full support during this journey," said Kuk, thanking invited the Director of the Institute, and wished the participants a productive and successful conference.
The conference, which will last until December 16, reportedly gathered over 200 participants and is an opportunity to discuss current topics and challenges and find innovative ways to improve regulation and practice in the field of drugs and medical devices.
"The conference program will primarily focus on topics related to the procedure for issuing a drug license, renewals and variations, then monitoring the consumption of drugs and pharmacovigilance, as well as the development of regulations in the field of medical devices. In addition, a scientific session was organized, which is a reflection of the commitment of the Institute for Research and Development," the announcement states.
The Institute added that this year's conference is characterized by a variety of topics, and they hope that the participants will take away useful insights and ideas that will enrich their professional development.
Bonus video:
